Delivery Order SPE2DR25D6044-SPE2DR26FYA1C
- Not listed
- The Defense Logistics Agency awarded a $2,518.74 delivery order to AmerisourceBergen Drug Corp on September 1, 2025, for the supply of Enoxaparin 40 mg/0.4 mL syringes with an ultimate completion date of September 2, 2025. This competitive award, priced on a firm fixed-price basis with no set-aside designation, represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical product will be delivered to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Enoxaparin 100 mg/ml syringes valued at $2,467.17. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of September 17, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $2,472.00 delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Enoxaparin 100 mg/ml syringes, with a completion date of September 25, 2025. This delivery order is issued under a firm fixed-price contract with no set-aside designation, indicating competitive award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a child contract under...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The $2,841.38 firm fixed price contract is for the supply of 100 mg/mL Enoxaparin syringes. This order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to provide pharmaceutical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,563,215,870 units of the drug Enoxaparin 40 mg/0.4 ml syringe. The contract has a firm fixed price of $1,204.92 and an ultimate completion date of January 3, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,478.35 firm fixed-price contract is for the delivery of 80 mg/0.8 mL syringes of the anticoagulant drug enoxaparin, with a completion date of December 4, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,558,043,689 units of Enoxaparin 60 mg/0.6 mL syringes. The contract has a ceiling value of $1,647.66 and an ultimate completion date of August 10, 2022. It is a firm-fixed-price contract type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,351.76 firm fixed-price delivery order is for the supply of 4567089316 units of 150 mg/mL enoxaparin syringes. The award has an ultimate completion date of January 30, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at thirty-two thousand four hundred eighty dollars to Amerisourcebergen Drug Corporation for the supply of forty milligrams per four-tenths milliliter enoxaparin syringes. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period spanning August seventeenth through eighteenth of twenty twenty-three. The prime contractor, Amerisourcebergen Drug Corporation, is a division of...
- This delivery order for enoxaparin syringes was awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corporation on October 18, 2023 for a potential value of four US dollars. Performance will take place in Conshohocken, Pennsylvania, with completion by October 19, 2023. The firm fixed price contract was awarded using no set-aside designation to supply the specified pharmaceutical product to the agency. As the Defense Logistics Agency manages the global supply chain for the US...
- SPE2DR25D6044Indefinite Delivery Contract
- SPE2DR25D6044-SPE2DR26FYA1CDelivery Order
The Defense Logistics Agency awarded a $7,664.99 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Enoxaparin 40 mg/0.4 ml syringes on November 5, 2025, with completion scheduled for November 6, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime vendor contract serves as a comprehensive global pharmaceutical support vehicle enabling the supply of a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs for military and veteran healthcare systems. The company's performance under the DLA Medical Supply Chain demonstrates its capability to fulfill competitive federal procurement requirements across multiple therapeutic domains. This delivery order for Enoxaparin—an anticoagulant medication commonly used in military medical settings—reflects the company's continued role as a critical vendor supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contract vehicles designed to ensure reliable pharmaceutical supply across global operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.7k | 11/5/25 |